Blue Crest Capital Management LTD Zoetis Inc. Transaction History

Blue Crest Capital Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$116.25 - $133.25 $422,336 - $484,097	-3,633 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$112.57 - $128.43 $408,966 - $466,586	3,633 New	3,633 $453,000
Q4 2018 Feb 14, 2019	SELL	$79.28 - $95.27 $312,838 - $375,935	-3,946 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$83.5 - $93.23 $3.03 Million - $3.38 Million	-36,256 Reduced 90.18%	3,946 $361,000
Q2 2018 Aug 14, 2018	BUY	$79.9 - $89.2 $3.21 Million - $3.59 Million	40,202 New	40,202 $3.43 Million
Q1 2018 May 15, 2018	SELL	$71.51 - $84.69 $231,191 - $273,802	-3,233 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$63.24 - $72.8 $204,454 - $235,362	3,233	3,233 $233,000

1,923

424M

1.15M

1.2M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $83.7B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.